Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib plus weekly carboplatin and paclitaxel in relapsed ovarian cancer
NCT01650376Phase 2Unknown
- Sponsor
- Swedish Health Services
- Start
- Aug 2012
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in ovarian cancer, uterine cancer, sponsored by Swedish Health Services. Status: unknown.
02
Drugs
olaparib
03
Conditions
ovarian canceruterine cancer
Beyond the preview
Go deeper on NCT01650376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650376.